These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2455675)

  • 1. Heterogeneity of calcium channel agonist binding sites in the coronary artery.
    Drímal J
    Gen Physiol Biophys; 1988 Apr; 7(2):135-42. PubMed ID: 2455675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranes.
    Sarmiento JG; Shrikhande AV; Janis RA; Triggle DJ
    J Pharmacol Exp Ther; 1987 Apr; 241(1):140-6. PubMed ID: 2437286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscle.
    Wei XY; Luchowski EM; Rutledge A; Su CM; Triggle DJ
    J Pharmacol Exp Ther; 1986 Oct; 239(1):144-53. PubMed ID: 2428971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
    Janis RA; Sarmiento JG; Maurer SC; Bolger GT; Triggle DJ
    J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of beta-adrenergic receptors and calcium channel agonist binding sites in cultured human embryonal smooth muscle cells.
    Drímal J
    Gen Physiol Biophys; 1989 Aug; 8(4):341-50. PubMed ID: 2475388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment in pig coronary artery of long-lasting and potent calcium antagonistic actions of the novel dihydropyridine derivative mepirodipine hydrochloride.
    Nakayama K; Kashiwabara T; Yamada S; Tanaka Y
    Arzneimittelforschung; 1989 Jan; 39(1):50-5. PubMed ID: 2470382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of [3H]nitrendipine binding sites in rat spinal cord.
    Gandhi VC; Jones DJ
    J Pharmacol Exp Ther; 1988 Nov; 247(2):473-80. PubMed ID: 2460614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel agonist and antagonist binding in a highly enriched sarcolemma preparation obtained from canine ventricle.
    Rampe D; Poder T; Zhao ZY; Schilling WP
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):547-56. PubMed ID: 2470991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A; Minarovic I; Zahradník I
    J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.
    Thomas G; Gross R; Schramm M
    J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist actions of Bay K 8644, a dihydropyridine derivative, on the voltage-dependent calcium influx in smooth muscle cells of the rabbit mesenteric artery.
    Kanmura Y; Itoh T; Kuriyama H
    J Pharmacol Exp Ther; 1984 Dec; 231(3):717-23. PubMed ID: 6209390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1-induced vascular contractions: interactions with drugs affecting the calcium channel.
    Stasch JP; Kazda S
    J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S63-6; discussion S74. PubMed ID: 2473330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of L-type calcium channels on stimulated calcium influx and on proliferative activity of human coronary smooth muscle cells.
    Kruse HJ; Bauriedel G; Heimerl J; Höfling B; Weber PC
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):328-35. PubMed ID: 7526069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Bay k 8644 on the coronary vascular selectivity of the dihydropyridine Ca antagonists in the canine isolated, blood-perfused papillary muscle preparation.
    Motomura S; Hashimoto K; Hashimoto K
    J Cardiovasc Pharmacol; 1987 Dec; 10(6):627-35. PubMed ID: 2450231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beta-adrenergic receptor-regulated 1,4-dihydropyridine calcium channel receptor sites in coronary artery smooth muscle.
    Drímal J
    Physiol Res; 1991; 40(5):481-91. PubMed ID: 1725962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of 1,4-dihydropyridine and beta-adrenergic receptor sites in coronary artery smooth muscle membranes.
    Drimal J
    Cell Signal; 1991; 3(3):225-32. PubMed ID: 1716451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific binding of a calcium channel activator, [3H]BAY k 8644, to membranes from cardiac muscle and brain.
    Janis RA; Rampe D; Sarmiento JG; Triggle DJ
    Biochem Biophys Res Commun; 1984 May; 121(1):317-23. PubMed ID: 6203531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
    Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the calcium channel agonist, Bay K-8644 on human vascular smooth muscle.
    Gopalakrishnan V; Park LE; Triggle CR
    Eur J Pharmacol; 1985 Jul; 113(3):447-51. PubMed ID: 2412849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
    Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
    Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.